Kimia Therapeutics

Berkeley, United States

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

$55.0M raised

Dec 2023

Series A

Biotechnology Therapeutics

Top Investors

Dimension CapitalThe Column GroupHorizons VenturesZachary Hargreaves

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kimia Therapeutics

How much funding has Kimia Therapeutics raised?

Kimia Therapeutics has raised $55.0M in total funding. The most recent round was Series A. The last funding was announced in December 2023.

Who are Kimia Therapeutics's investors?

Kimia Therapeutics's investors include Dimension Capital, The Column Group, Horizons Ventures, Zachary Hargreaves.

Where is Kimia Therapeutics headquartered?

Kimia Therapeutics is headquartered in Berkeley, United States.

What does Kimia Therapeutics do?

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

What stage is Kimia Therapeutics at?

Kimia Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2023.

MLA

"Kimia Therapeutics — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/kimia-therapeutics. Accessed June 10, 2026.

APA

VCBacked. (2023). Kimia Therapeutics — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/kimia-therapeutics

Wikipedia (cite web)

{{cite web |title=Kimia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kimia-therapeutics |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2023.

Similar Companies in Biotechnology